The global acetylcholine market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for acetylcholine in various applications such as neurotransmitters, vasodilator agents, and cholinergic agonists. Acetylcholine is used as a neurotransmitter in the central nervous system and peripheral nervous system. It is also used as a vasodilator agent for treating hypertension and other cardiovascular diseases. Acetylcholine has been found to be effective in treating Alzheimer’s disease by improving cognitive functions such as memory, attention span, and problem-solving skills.
Liquid form acetylcholine accounted for the largest share of this market in 2018 owing to its wide range of applications across various industries such as pharmaceuticals & biotechnology, food & beverages, chemicals & plastics manufacturing industry among others. Solid form acetylcholine accounted for the second largest share due to its high stability against heat or light exposure which makes it suitable for use in various industrial processes including chemical synthesis or polymerization reactions among others.
- Acetylcholine is a neurotransmitter that is involved in the transmission of nerve impulses to muscles and glands.
- Acetylcholine is also a major component of the parasympathetic nervous system, which controls involuntary actions such as heart rate, digestion, and breathing.
- The drug Donepezil has been approved by the FDA for treatment of Alzheimer's disease and other forms of dementia.
- The drug Tacrine has been approved by the FDA for treatment of Alzheimer's disease.
- There are many drugs that act on acetylcholine receptors.
Industry Growth Insights published a new data on “Acetylcholine Market”. The research report is titled “Acetylcholine Market research by Types (Liquid Form Acetylcholine, Solid Form Acetylcholine), By Applications (Neurotransmitters, Vasodilator Agents, Cholinergic Agonists, Others), By Players/Companies Tokyo Chemical Industry, Merck KGaA, NeuroHealing Pharmaceuticals, Karuna Pharmaceuticals, Sosei Heptares, Sumitomo Dainippon Pharma, AstraZeneca, Anavex Life Sciences”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Acetylcholine Market Research Report
By Type
Liquid Form Acetylcholine, Solid Form Acetylcholine
By Application
Neurotransmitters, Vasodilator Agents, Cholinergic Agonists, Others
By Companies
Tokyo Chemical Industry, Merck KGaA, NeuroHealing Pharmaceuticals, Karuna Pharmaceuticals, Sosei Heptares, Sumitomo Dainippon Pharma, AstraZeneca, Anavex Life Sciences
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Acetylcholine Market Report Segments:
The global Acetylcholine market is segmented on the basis of:
Types
Liquid Form Acetylcholine, Solid Form Acetylcholine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Neurotransmitters, Vasodilator Agents, Cholinergic Agonists, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Tokyo Chemical Industry
- Merck KGaA
- NeuroHealing Pharmaceuticals
- Karuna Pharmaceuticals
- Sosei Heptares
- Sumitomo Dainippon Pharma
- AstraZeneca
- Anavex Life Sciences
Highlights of The Acetylcholine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid Form Acetylcholine
- Solid Form Acetylcholine
- By Application:
- Neurotransmitters
- Vasodilator Agents
- Cholinergic Agonists
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Acetylcholine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Acetylcholine is a neurotransmitter that helps to transmit signals between nerve cells. It is also responsible for controlling muscle movement and the secretion of saliva, sweat, and tears.
Some of the major companies in the acetylcholine market are Tokyo Chemical Industry, Merck KGaA, NeuroHealing Pharmaceuticals, Karuna Pharmaceuticals, Sosei Heptares, Sumitomo Dainippon Pharma, AstraZeneca, Anavex Life Sciences.
The acetylcholine market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Acetylcholine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Acetylcholine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Acetylcholine Market - Supply Chain
4.5. Global Acetylcholine Market Forecast
4.5.1. Acetylcholine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Acetylcholine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Acetylcholine Market Absolute $ Opportunity
5. Global Acetylcholine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Acetylcholine Market Size and Volume Forecast by Type
5.3.1. Liquid Form Acetylcholine
5.3.2. Solid Form Acetylcholine
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Acetylcholine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Acetylcholine Market Size and Volume Forecast by Application
6.3.1. Neurotransmitters
6.3.2. Vasodilator Agents
6.3.3. Cholinergic Agonists
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Acetylcholine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Acetylcholine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Acetylcholine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Acetylcholine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Acetylcholine Demand Share Forecast, 2019-2026
9. North America Acetylcholine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Acetylcholine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Acetylcholine Market Size and Volume Forecast by Application
9.4.1. Neurotransmitters
9.4.2. Vasodilator Agents
9.4.3. Cholinergic Agonists
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Acetylcholine Market Size and Volume Forecast by Type
9.7.1. Liquid Form Acetylcholine
9.7.2. Solid Form Acetylcholine
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Acetylcholine Demand Share Forecast, 2019-2026
10. Latin America Acetylcholine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Acetylcholine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Acetylcholine Market Size and Volume Forecast by Application
10.4.1. Neurotransmitters
10.4.2. Vasodilator Agents
10.4.3. Cholinergic Agonists
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Acetylcholine Market Size and Volume Forecast by Type
10.7.1. Liquid Form Acetylcholine
10.7.2. Solid Form Acetylcholine
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Acetylcholine Demand Share Forecast, 2019-2026
11. Europe Acetylcholine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Acetylcholine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Acetylcholine Market Size and Volume Forecast by Application
11.4.1. Neurotransmitters
11.4.2. Vasodilator Agents
11.4.3. Cholinergic Agonists
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Acetylcholine Market Size and Volume Forecast by Type
11.7.1. Liquid Form Acetylcholine
11.7.2. Solid Form Acetylcholine
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market AttractivenessGrowth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Acetylcholine Demand Share, 2019-2026
12. Asia Pacific Acetylcholine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Acetylcholine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Acetylcholine Market Size and Volume Forecast by Application
12.4.1. Neurotransmitters
12.4.2. Vasodilator Agents
12.4.3. Cholinergic Agonists
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Acetylcholine Market Size and Volume Forecast by Type
12.7.1. Liquid Form Acetylcholine
12.7.2. Solid Form Acetylcholine
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Acetylcholine Demand Share, 2019-2026
13. Middle East & Africa Acetylcholine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Acetylcholine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Acetylcholine Market Size and Volume Forecast by Application
13.4.1. Neurotransmitters
13.4.2. Vasodilator Agents
13.4.3. Cholinergic Agonists
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Acetylcholine Market Size and Volume Forecast by Type
13.7.1. Liquid Form Acetylcholine
13.7.2. Solid Form Acetylcholine
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Acetylcholine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Acetylcholine Market: Market Share Analysis
14.2. Acetylcholine Distributors and Customers
14.3. Acetylcholine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Tokyo Chemical Industry
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck KGaA
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. NeuroHealing Pharmaceuticals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Karuna Pharmaceuticals
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sosei Heptares
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sumitomo Dainippon Pharma
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. AstraZeneca
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Anavex Life Sciences
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
